Frost & Sullivan: New Testing Options Bring Prenatal Testing Market to the Forefront in the U.S.

Frost & Sullivan: New Testing Options Bring Prenatal Testing Market to the Forefront in the U.S. PR Newswire MOUNTAIN VIEW, California, June 5, 2012 - Prenatal testing services are an option for parents-to-be MOUNTAIN VIEW, California, June 5, 2012 /PRNewswire/ -- Prenatal testing is an available choice for pregnant women around the world to obtain information at their discretion about the fetus they are carrying. Women may choose to detect chromosome abnormalities in the fetus. For example, mothers-to-be are often told by their OBGYNs about the increased risk of chromosomal abnormality with advanced maternal age. In the United States, the trend of increasing maternal age for women may also increase the use of prenatal tests. Analysis from Frost & Sullivan's (http://www.clinicaldiagnostics.frost.com) Strategic Analysis of the U.S. Prenatal Testing Market research finds that the market earned revenues of $1.28 billion in 2010 and estimates this to reach $1.59 billion in 2017. In this analysis, Frost & Sullivan's in vitro diagnostic (IVD) industry analysts thoroughly examine the following market segments: maternal serum screen, nuchal translucency (NT) ultrasound, karyotype, prenatal fluorescent in situ hybridization (FISH), and prenatal chromosomal array. If you are interested in more information on this research, please send an email to Britni Myers, Corporate Communications, at britni.myers@frost.